Home/Filings/4/0001127602-24-029847
4//SEC Filing

Jejurikar Shailesh 4

Accession 0001127602-24-029847

CIK 0000080424other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 12:53 PM ET

Size

13.4 KB

Accession

0001127602-24-029847

Insider Transaction Report

Form 4
Period: 2024-12-19
Jejurikar Shailesh
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2024-11-15+30.228489.601 total
    Common Stock (30.228 underlying)
  • Tax Payment

    Common Stock

    2024-12-19$169.79/sh46.27$7,8569,914.357 total
  • Exercise/Conversion

    Common Stock

    2024-12-19$169.79/sh+46.27$7,8569,960.627 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-1946.27602.73 total
    Common Stock (46.27 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    2,925.759
  • Common Stock

    (indirect: By Trust)
    19,757
  • Common Stock

    (indirect: By Trust)
    17,849
Footnotes (6)
  • [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
  • [F2]Shares withheld to cover taxes on previous Restricted Stock Unit grant.
  • [F3]Reflects adjustment to PST through September 30, 2024.
  • [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
  • [F6]Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2024.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001746310

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 12:53 PM ET
Size
13.4 KB